This opportunity is no longer accepting applications.
grant RFA-DA-25-014

Microglial Pathophysiology in Comorbid Substance Use Disorder (SUD) and HIV (R61/R33 Clinical Trial Not Allowed)

This grant aims to study microglial protein profiles in specific brain regions and cell types related to HIV and substance use disorders (SUD). The research will use these profiles to understand how HIV-infected microglia contribute to brain diseases in individuals with both HIV and SUD.

The goal of this funding opportunity announcement is to generate brain region and cell-type specific microglial protein profiles in the context of HIV and SUD, then use those molecular profiles and interaction networks to establish mechanisms of how HIV-harboring microglia may contribute specifi…

Funding Source

Agency: National Institutes of Health
Sub-agency: National Institute on Drug Abuse

Dates

Opportunity Released: July 19, 2023
Open for Submission: July 19, 2023
Submission Deadline: August 14, 2025
Application Window Closes: August 14, 2025

Supporting links

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.